ارتباط الأجسام المضادة للببتيد المضاد للسيترولينات والانزيم المزيل للفوسفات القاعدي   المرضى المصابين بألتهاب المفاصل الرثوي

Bullock J, Rizvi SA, Saleh AM, Ahmed SS, DP Do, Ansari RA, et.al. Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract. 2019; 27 (6): 501–507. https://doi.org/10.1159/000493390

Gravallese EM, Firestein GS. Rheumatoid Arthritis - Common Origins, Divergent Mechanisms. N Engl J Med. 2023; 388(6): 529-542.https://doi.org/10.1056/NEJMra2103726.

Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. ‏The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021; 41: 863–877.

Al-Rawi ZS, Alazzawi AJ, Alajili FM, Alwakil R. Rheumatoid arthritis in population samples in Iraq. Ann Rheum Dis. 1978; 37(1):73-75.https://doi.org/10.1136%2Fard.37.1.73.

Camille Brewer, Tobias V Lanz, Caryn R Hale, Gregory D Sepich-Poore, Cameron Martino, Austin D Swafford, et.al. Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis. Sci Transl Med. 2023; 15(684): 76-84.https://doi.org/10.1126/scitranslmed.abq8476.

Studenic P, Alunno A, Sieghart D, Bang H, Aletaha D, Blüml S. et.al. Presence of anti-acetylated peptide antibodies (AAPA) in inflammatory arthritis and other rheumatic diseases suggests discriminative diagnostic capacity towards early rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2021; 13: 1–15. https://doi.org/10.1177/1759720X211022533

Sokolova MV, Schett G, Steffen U. Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clinic Rev Allerg Immunol. 2022; 63: 138–151.https://doi.org/10.1007/s12016-021-08890-1

Yi Wu CH, Yu Yang H, Haung Lai J. Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis. Int J Mol Sci. 2020; 21(11): 1-23. https://doi.org/10.3390/ijms21114015.

Scherer HU, van der Woude D, Toes R E M. From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis. Nat Rev Rheumatol. 2022; 18: 371–383. https://doi.org/10.1038/s41584-022-00786-4

Farhana A, Lappin SL. Biochemistry, Lactate Dehydrogenase. In: StatPearls Publishing, Treasure Island (FL). Europe PMID. 2022: 32491468. https://europepmc.org/article/nbk/nbk557536#free-full-text

Manosalva C, Quiroga J, Hidalgo AI, Alarcon P, Anseoleaga N, Hidalgo MA. et.al. Role of lactate in inflammatory processes: Friend or foe. Front Immunol. 2022; 12: 799- 808. https://doi.org/10.3389/fimmu.2021.808799.

Ma Y, Zhang Xu, Fan D, Xia Q, Wang M, Pan F. Common trace metals in rheumatoid arthritis: A systematic review and meta-analysis. J Trace Elem Med Biol. 2019; 56: 81-89. https://doi.org/10.1016/j.jtemb.2019.07.007.

Frangos T, Maret W. Zinc and cadmium in the aetiology and pathogenesis of osteoarthritis and rheumatoid arthritis. Nutrients. 2021; 13(1): 23-45. https://doi.org/10.3390/nu13010053.

Marreiro DD, Cruz KJ, Morais JB, Beserra JB, Severo JS, De Oliveira AR. Zinc and oxidative stress: current mechanisms. Antioxidants. 2017; 6(2): 1124-1129. https://doi.org/10.3390/antiox6020024.

Mirończuk-Chodakowska I, Socha K, Zujko ME, Terlikowska KM, Borawska MH, Witkowska AM. Copper, Manganese, Selenium and Zinc in Wild-Growing Edible Mushrooms from the Eastern Territory of “Green Lungs of Poland”: Nutritional and Toxicological Implications. Int J Environ Res Public Health. 2019; 16(19): 14-36.https://doi.org/10.3390/ijerph16193614.

Christensen DG, Xie X, Basisty N, Byrnes J, McSweeney S, Schilling B, et.al. Post-translational protein acetylation: an elegant mechanism for bacteria to dynamically regulate metabolic functions. Front Microbiol. 2019; 10: 1604-1626. https://doi.org/10.3389/fmicb.2019.01604.

Kurowska W, Kuca-Warnawin EH, Radzikowska A, Maśliński W. The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Centr Eur J Immunol. 2017; 42 (4): 390-398. https://doi.org/10.5114/ceji.2017.72807.

Sonigra A, Nel HJ, Wehr P, Ramnoruth N, Patel S, van Schie KA, et.al. Thomas R. Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis. JCI Insight. 2022; 7(20): 1-17. https://doi.org/10.1172/jci.insight.160964.

Van Gaalen FA, Van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, et.al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheumatol. 2004; 50: 2113-2121. https://doi.org/10.1002/art.20316.

Zhang P, Zhang X, Xu F, Xu W, Zhu H. Elevated expression of interleukin-27, IL-35, and decreased IL-12 in patients with thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2023; 261: 1091–1100. https://doi.org/10.1007/s00417-022-05856-7.

Chirivi RG, van Rosmalen JW, van der Linden M, Euler M, Schmets G, Bogatkevich G, et.al. Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases. Cell Mol Immunol. 2021; 18: 1528–1544. https://doi.org/10.1038/s41423-020-0381-3.

Catrina A, Krishnamurthy A, Rethi B. Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis. RMD open. 2021; 7 (1): 1-9. https://doi.org/10.1136/rmdopen-2020-001228.

Malmström V, Grönwall C. The parallel worlds of ACPA-positive and RF-positive B cells. Nat Rev Rheumatol.2018; 14:626–628. https://doi.org/10.1038/s41584-018-0094-5.

Jonsson MK, Hensvold AH, Hansson M, Aga AB, Sexton J, Mathsson-Alm L, et.al. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy. Arthritis Res Ther. 2018; 20: 1-11. https://doi.org/10.1186/s13075-018-1635-7

Al-Ani N, Gorial F, Yasiry D, Al Derwibee F, Abbas Humadi Y, Sunna N, et.al. Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept. Open Access Rheumatol.: Res Rev. 2021; 13: 57-62. https://doi.org/10.2147/OARRR.S300838.

Niitsu N, Okamoto M, Nakamine H, Hirano M. Clinicopathologic correlations of diffuse large B‐cell lymphoma in rheumatoid arthritis patients treated with methotrexate. Cancer Sci. 2010; 101(5): 1309-1313. https://doi.org/10.1111/j.1349-7006.2010.01517.x

Wang Q, Asenso J, Xiao N, Gao J, Xiao F, Kuai J, et.al. Lactic Acid Regulation: A Potential Therapeutic Option in Rheumatoid Arthritis. J Immunol Res. 2022; 2022: 1-11. https://doi.org/10.1155/2022/2280973.

Al-Hindawi M, Al-Gebori A, Alosami M. Tenascin-C and Interleukin-17 Up-regulation in Axial Spondyloarthritis Patients. Rheumatology (Bulgaria).2023; 30(4): 3-11. https://doi.org/10.35465/30.4.2022.pp3-11.

Xin L, Yang X, Cai G, Fan D, Xia Q, Liu L,et.al. Serum levels of copper and zinc in patients with rheumatoid arthritis: a meta-analysis. Biol Trace Elem Res .2015; 168: 1–10. https://doi.org/10.1007/s12011-015-0325-4.

Al-Timimi DJ, Al-Sharbatti SS, Al-Najjar F. Zinc deficiency among a healthy population in Baghdad, Iraq. Saudi Med J. 2005; 26(11): 1777-1781. https://europepmc.org/article/med/16311665

Liu Y, Zhu J, Xu L, Wang B, Lin W, Luo Y. Copper regulation of immune response and potential implications for treating orthopedic disorders. Front Mol Biosci. 2022; 9: 1065265. https://doi.org/10.3389/fmolb.2022.1065265 .

Oleiwi Ahmed R, ZGAIR Ayaid Khadem. Estimation levels of CTHRC1and some cytokines in Iraqi patientswith Rheumatoid Arthritis. Baghdad Sci J. 2023; 20(3): 928-936.‏ https://doi.org/10.21123/bsj.2023.8036.

Findeisen KE, Sewell J, Ostor AJ. Biological therapies for rheumatoid arthritis: an overview for the clinician. Biol: Targets Ther. 2021; 15: 343-352. https://doi.org/10.2147/BTT.S252575.

Halestrap AP, Wilson MC. The monocarboxylate transporter family—role and regulation. IUBMB life. 2012; 64(2): 109-119. https://doi.org/10.1002/iub.572.

Cunningham KY, Hur B, Gupta VK, Arment CA, Wright KA, Mason TG, et.al.Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity. Sci Rep. 2023; 13: 5360. https://doi.org/10.1038/s41598-023-32428-4.

Mohammed N U G, Khaleel F M and Gorial F I. The Role of Serum Chitinase-3-Like 1 Protein (YKL-40) Level and its Correlation with Proinflammatory Cytokine in Patients with Rheumatoid Arthritis. Baghdad Sci J. 2022; 19(5): 1014-1020.‏ http://dx.doi.org/10.21123/bsj.2022.6293.